Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 18, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Consolidated Net Income (2022 - 2026)

Bioregenx (BRGX) posted Consolidated Net Income of -$126850.0 for Q1 2026, up 87.54% on a QoQ basis from -$1.0 million in Q4 2025, and up 52.46% year-over-year from -$83199.6 in Q1 2025.

Analysis

Bioregenx (BRGX) Consolidated Net Income (2022 - 2026) Analysis & Trends

Bioregenx has reported Consolidated Net Income for 5 years, with the latest figure at -$126850.0 in Q1 2026.

  • On a quarterly basis, Consolidated Net Income rose 52.46% year-over-year to -$126850.0 in Q1 2026; TTM through Mar 2026 was -$1.4 million, a 93.04% increase from a year earlier, with the FY2025 full-year figure at -$1.5 million, up 93.3% from the prior year.
  • Consolidated Net Income was -$126850.0 for Q1 2026 at Bioregenx, up from -$1.0 million in the prior quarter.
  • The five-year high for Consolidated Net Income was -$2191.0 in Q3 2022, with the low at -$18.4 million in Q4 2024.
  • Average Consolidated Net Income over 5 years is -$1.4 million, with a median of -$178345.0 recorded in 2025.
  • The sharpest annual moves came in 2024 and 2025: Consolidated Net Income sank 26695.74% in 2024, then soared 94.47% in 2025.
  • Over 5 years, Consolidated Net Income stood at -$30535.0 in 2022, then tumbled by 2257.84% to -$719966.0 in 2023, then tumbled by 2455.76% to -$18.4 million in 2024, then jumped by 94.47% to -$1.0 million in 2025, then soared by 87.54% to -$126850.0 in 2026.
  • The last three Consolidated Net Income figures came in at -$126850.0 (Q1 2026), -$1.0 million (Q4 2025), and -$80565.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Abbott Laboratories 177.43 Bn 172.48 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 139.20 Bn 134.11 Bn 1.96 Bn 823.20 Mn
3 Medtronic 118.01 Bn 109.81 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.44 Bn 101.96 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 62.90 Bn 62.60 Bn 3.85 Bn 905.00 Mn
6 Edwards Lifesciences 50.87 Bn 46.72 Bn 1.35 Bn 241.40 Mn
7 Dexcom 33.72 Bn 31.77 Bn 830.00 Mn 249.10 Mn
8 Resmed 32.45 Bn 30.98 Bn 861.22 Mn 383.43 Mn
9 Alcon 31.70 Bn 30.25 Bn 1.68 Bn -92.00 Mn
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 -126,850.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -126,850.00
Dec 31, 2025 -1.02 Mn
Sep 30, 2025 -80,565.00
Jun 30, 2025 -178,345.00
Mar 31, 2025 -266,854.00
Dec 31, 2024 -18.40 Mn
Sep 30, 2024 -394,860.00
Jun 30, 2024 -1.11 Mn
Mar 31, 2024 -704,806.00
Dec 31, 2023 -719,966.00
Sep 30, 2023 -3,691.00
Jun 30, 2023 -4,128.00
Mar 31, 2023 -229,838.00
Dec 31, 2022 -30,535.00
Sep 30, 2022 -2,191.00
Jun 30, 2022 -33,263.00
Mar 31, 2022 -37,319.00
API Access

Bioregenx Consolidated Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=BRGX&period=max&api_key=YOUR_API_KEY